Cargando…
Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer
AIM: Peritoneal metastases (PM) frequently occur in patients with gastric cancer and result in a poor prognosis. Exosomes play pivotal roles in tumor metastasis through the transfer of microRNAs (miRNAs). We examined the exosomal miRNA profile in peritoneal fluids to identify novel biomarkers to ref...
Autores principales: | Ohzawa, Hideyuki, Kumagai, Yuko, Yamaguchi, Hironori, Miyato, Hideyo, Sakuma, Yasunaru, Horie, Hisanaga, Hosoya, Yoshinori, Kawarai Lefor, Alan, Sata, Naohiro, Kitayama, Joji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992685/ https://www.ncbi.nlm.nih.gov/pubmed/32021962 http://dx.doi.org/10.1002/ags3.12296 |
Ejemplares similares
-
Treatment of patients with peritoneal metastases from gastric cancer
por: Kitayama, Joji, et al.
Publicado: (2018) -
Reduced expression of exosomal miR-29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement
por: Ohzawa, Hideyuki, et al.
Publicado: (2020) -
Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases
por: Saito, Shin, et al.
Publicado: (2020) -
Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
por: Takahashi, Kazuya, et al.
Publicado: (2022) -
Flow cytometry‐based analysis of tumor‐leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer
por: Takahashi, Kazuya, et al.
Publicado: (2020)